Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Orphan drug status for OGP(10-14)L for chronic idiopathic myelofibrosis

Oct. 8, 2003

Scientists at Pfizer discover new beta3-adrenoceptor agonists

Oct. 8, 2003

Barr to acquire Plan B emergency contraceptive

Oct. 7, 2003

New xanthine oxidase inhibitors described in Fuji Yakuhin patent

Oct. 7, 2003

Pfizer team identifies new glycogen phosphorylase inhibitors for diabetes and related disorders

Oct. 7, 2003

Novel lipase inhibitors prepared and tested by Aventis scientists

Oct. 7, 2003

Novel NPY Y5 antagonists prepared and tested at Roche

Oct. 6, 2003

Lack of synergy described for alendronate and PTH in osteoporosis

Oct. 6, 2003

CERA: a potent and long-acting erythropoietic agent

Oct. 3, 2003

TKT to report one-year phase I/II results for I2S at upcoming genetics meeting

Oct. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...